Saudi Arabia Pavilion

Saudi Arabia Pavilion

SP
Company Profile

Saudi Arabia Pavilion

Riyadh, Saudi Arabia

الرئيسية عن الوزارة نبذة عن الوزارة مؤشرات الصحة هيكل الوزارة الاستراتيجيات والسياسات والتزامات الخدمة الميزانية والإنفاق منافسات ومشتريات الوزارة
0Products
0People
0Events
0Locations

Overview

Company details and contact information.

About

About Saudi Arabia Pavilion Saudi Arabia is boldly shaping the future of biotechnology with unmatched ambition. Guided by its National Biotech Strategy launched in 2024, the Kingdom aims to become a leading global biotech hub by 2040 - focusing on developing a thriving, innovation focused sector contributing up to 3% of the country's GDP. As part of Vision 2030, Saudi Arabia’s healthcare system is undergoing a systemic transformation to become more integrated, effective, and future-ready. The Kingdom has made - and will continue to make significant investments in world-class research institutions and cutting-edge infrastructure to power the biotech sector's growth. In addition to its strong foundation, Saudi Arabia boasts a sophisticated and mature regulatory framework for red/medical biotech. This is underscored by its recognition from the WHO, which awarded the SFDA Maturity Level Four (ML4) for medicines and vaccines regulation - the highest level in the WHO’s classification of regulatory authorities for medical products. These advancements are further reinforced by growing private sector participation, including strategic partnerships with leading research institutions and substantial investments in expanding the Kingdom’s biomanufacturing capabilities Saudi Arabia’s strategic geographic location connects major emerging markets with a business-friendly environment and a fast and agile decision making to allow for speedy approvals. The Kingdom is a regional leader in genomic R&D, backed by advanced large-scale sequencing infrastructure, strong academic engagement, and impactful research - evidenced by over 100 published papers from the Saudi Human Genome Program since 2014 and a growing network of ~90 genomics researchers. In parallel, Saudi Arabia has invested several billion dollars in digital health infrastructure, building centralized health data platforms that support telemedicine, mobile health, remote monitoring, AI applications, and other cutting-edge digital health solutions. Join us at the KSA Pavilion to explore Saudi Arabia’s rapidly evolving biotech ecosystem. Discover the Kingdom’s livability, regulatory and funding landscape, connect with leading research institutions, and engage with key organizations driving KSA's biotech frontier.

Address
Ministry of Health, Digital City, Tower 2, Riyadh, Saudi Arabia